Burden of disease associated with asthma among the adult general population of five Middle Eastern countries: Results of the SNAPSHOT program
Affiliations
Affiliations
- Department of Chest Diseases, Division of Allergy and Immunology, Ankara University, School of Medicine, Turkey. Electronic address: dilsadmungan@gmail.com.
- Department of Chest Diseases, Division of Allergy and Immunology, Ankara University, School of Medicine, Turkey. Electronic address: mdomuraydin@gmail.com.
- College of Medicine, University of Sharjah, Sharjah, UAE and Department of Pulmonary Medicine, Rashid Hospital, Dubai, United Arab Emirates. Electronic address: drbassam_mahboub@yahoo.com.
- Chest Medicine Department, Zain Hospital, Kuwait. Electronic address: Albader1219@yahoo.com.
- The Medical School, Cairo University, Cairo, Egypt. Electronic address: tarraf_hisham@hotmail.com.
- Foxymed, Paris, France. Electronic address: adam@foxymed.com.
- MS Health, Rabat, Morocco. Electronic address: alahlou@mshealth.ma.
- GlaxoSmithKline, Dubai, United Arab Emirates. Electronic address: luqman.l.tariq@gsk.com.
- GlaxoSmithKline, Dubai, United Arab Emirates. Electronic address: fayaz.a.aziz@gsk.com.
- GlaxoSmithKline, Dubai, United Arab Emirates. Electronic address: abdelkader.a.el-hasnaoui@gsk.com.
Abstract
Background: Asthma affects millions worldwide resulting in a significant disease burden. However, data on asthma burden from the Middle East is limited. This analysis describes the asthma burden in Egypt, Turkey and a Gulf cluster (Kuwait, Saudi Arabia and United Arab Emirates) as part of the SNAPSHOT program.
Methods: SNAPSHOT was an observational, cross-sectional program carried out by telephone in a random sample of the adult general population of the five above mentioned countries. Quotas were defined per country demographics. Subjects were considered to have asthma if they fulfilled the screening criteria, based on the global Asthma Insights and Reality studies. Data collected included demographics, physician consultations, and asthma control (measured by the Asthma Control Test; ACT). Quality of life was assessed using the EuroQol Five-Dimension questionnaire (EQ-5D); and limitations to daily activities using the modified Sheehan Disability Scale (SDS).
Results: 939 subjects answered questions related to asthma burden. Overall, 367 (44.2%) reported uncontrolled asthma (ACT≤19), and reported significantly lower EQ-5D-3L utility values (0.6 ± 0.4) and EQ-VAS scores (60.7 ± 24.2) compared to controlled subjects (0.8 ± 0.3 and 75.3 ± 19.8 respectively) (p < 0.0001). A significantly higher proportion with uncontrolled asthma also reported experiencing impact on activities of daily living compared to subjects with controlled asthma (p < 0.0001). Overall, 355 (37.8%) asthma subjects were followed by a physician. However, most visits were unscheduled (695;78.0%).
Conclusion: Uncontrolled asthma imposes a significant burden in these Middle Eastern countries resulting in increased frequency of healthcare use, lower quality of life, and a higher impact on daily life compared to controlled asthma.
Keywords: Asthma; Burden of disease; Middle East; SNAPSHOT.
Similar articles
Tarraf H, Aydin O, Mungan D, Albader M, Mahboub B, Doble A, Lahlou A, Tariq L, Aziz F, El Hasnaoui A.BMC Pulm Med. 2018 May 11;18(1):68. doi: 10.1186/s12890-018-0621-9.PMID: 29751756 Free PMC article.
Al-Digheari A, Mahboub B, Tarraf H, Yucel T, Annesi-Maesano I, Doble A, Lahlou A, Tariq L, Aziz F, El Hasnaoui A.Allergy Asthma Clin Immunol. 2018 Nov 19;14:63. doi: 10.1186/s13223-018-0298-x. eCollection 2018.PMID: 30473712 Free PMC article.
Noweir A, Abusamra A, Al Zarooni A, Binbay M, Doble A, Tariq L, Aziz F, El Hasnaoui A.Arab J Urol. 2022 Jan 23;20(1):14-23. doi: 10.1080/2090598X.2021.2010451. eCollection 2022.PMID: 35223105 Free PMC article.
Systemic review of the epidemiology of autism in Arab Gulf countries.
Salhia HO, Al-Nasser LA, Taher LS, Al-Khathaami AM, El-Metwally AA.Neurosciences (Riyadh). 2014 Oct;19(4):291-6.PMID: 25274588 Free PMC article. Review.
Asthma: epidemiology, burden, and quality of life.
Morgan M, Khan DA.Adv Psychosom Med. 2003;24:1-15. doi: 10.1159/000073776.PMID: 14584344 Review. No abstract available.
Cited by
Oh BC, Lee JE, Nam JH, Hong JY, Kwon SH, Lee EK.Front Pharmacol. 2022 Nov 21;13:908837. doi: 10.3389/fphar.2022.908837. eCollection 2022.PMID: 36479200 Free PMC article.
Alzaabi A, Al Busaidi N, Pradhan R, Shandy F, Ibrahim N, Ashtar M, Khudadah K, Hegazy K, Samir M, Negm M, Farouk H, Al Khalidi A, Beekman M.Asthma Res Pract. 2022 Jul 7;8(1):3. doi: 10.1186/s40733-022-00085-5.PMID: 35799290 Free PMC article.
Challenges and recommendations for the management of asthma in the Middle East and Africa.
Zeitouni MO, Al-Moamary MS, Coussa ML, Riachy M, Mahboub B, AlHuraish F, Zidan MH, Metwally MM, Aksu K, Yavuz E, Kalla IS, Chakaya J, Abdelmadjid S, Ghedira H.Ann Thorac Med. 2022 Apr-Jun;17(2):71-80. doi: 10.4103/atm.atm_469_21. Epub 2022 Apr 19.PMID: 35651897 Free PMC article. Review.
Alomary SA, Al Madani AJ, Althagafi WA, Adam IF, Elsherif OE, Al-Abdullaah AA, Al-Jahdali H, Jokhdar HA, Alqahtani SH, Nahhas MA, Alfawaz RA.World Allergy Organ J. 2022 Jan 10;15(1):100623. doi: 10.1016/j.waojou.2021.100623. eCollection 2022 Jan.PMID: 35079318 Free PMC article.
Al Mazrouei K, Almannaei AI, Nur FM, Bachnak N, Alzaabi A.Clinicoecon Outcomes Res. 2021 Dec 29;13:969-980. doi: 10.2147/CEOR.S331499. eCollection 2021.PMID: 35002264 Free PMC article.